Vytorin and Blood glucose abnormal - a phase IV clinical study of FDA data

Summary:

Blood glucose abnormal is reported as a side effect among people who take Vytorin (ezetimibe; simvastatin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Byetta, and have Diabetes.

The phase IV clinical study analyzes which people have Blood glucose abnormal when taking Vytorin. It is created by eHealthMe based on reports of 19,379 people who have side effects when taking Vytorin from the FDA, and is updated regularly.

What is Vytorin?

Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 20,084 Vytorin users. Check the latest studies of Vytorin.

What is Blood glucose abnormal?

Blood glucose abnormal is found to be associated with 879 drugs and 812 conditions by eHealthMe. Check the latest studies of Blood glucose abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

19,379 people reported to have side effects when taking Vytorin.
Among them, 31 people (0.16%) have Blood glucose abnormal.

Could Vytorin cause Blood glucose abnormal?

Among these 31 people:

How long have people been on Vytorin when they have Blood glucose abnormal? *

What is the gender of people who have Blood glucose abnormal when taking Vytorin? *

female: 54.84 %
male: 45.16 %

What is the age of people who have Blood glucose abnormal when taking Vytorin? *

What are other drugs people take besides Vytorin? *

What are other side effects people have besides Blood glucose abnormal? *

Weight Decreased: 9 people, 29.03%
Nausea And Vomiting: 6 people, 19.35%
Pancreatitis (inflammation of pancreas): 6 people, 19.35%
Drug Ineffective: 5 people, 16.13%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 16.13%
Nausea (feeling of having an urge to vomit): 4 people, 12.90%
Diarrhea: 4 people, 12.90%
Blood Glucose Increased: 4 people, 12.90%
Blood Glucose Decreased: 4 people, 12.90%
Acute Kidney Failure: 4 people, 12.90%

What are the existing conditions these people have? *

Diabetes: 10 people, 32.26%
Type 2 Diabetes: 9 people, 29.03%
Nausea (feeling of having an urge to vomit): 3 people, 9.68%
Dyslipidaemia (abnormal amount of lipids): 3 people, 9.68%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.45%
Type 1 Diabetes: 2 people, 6.45%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 6.45%
Dizziness: 1 person, 3.23%
Depression: 1 person, 3.23%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Vytorin and have Blood glucose abnormal?

- Check whether Blood glucose abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vytorin:

Vytorin (20,084 reports)

Browse all side effects of Vytorin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood glucose abnormal:

Blood glucose abnormal (879 drugs)

Browse all the conditions that are associated with Blood glucose abnormal:

Blood glucose abnormal (812 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe; simvastatin (the active ingredients of Vytorin) and Vytorin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.